CORRINGHAM, Robert E.,O,DONNELL, Patrick B.,JAMES, Joyce K.
申请号：
LT10719218
公开号：
LT2429524T
申请日:
2010.05.14
申请国别(地区):
LT
年份:
2020
代理人:
摘要：
Provided herein are methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N&prime；-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or a pharmaceutically acceptable salt or solvate thereof, to human patients, including a specific patient population. Specifically, dosing, dosing schedules or dosing regimens are provided herein. Methods of treating proliferative diseases or FLT-3 mediated diseases in humans are also provided.
